Background: Cytomegalovirus (CMV), a problematic virus in solid organ transplant
recipients (SOTR) such as liver, can worsen overall mortality and transplant outcome, so its …

Background Recent studies have demonstrated that cytomegalovirus (CMV) infection and
disease are associated with increased risk of graft loss and death in high‐risk (donor CMV …

BACKGROUND: Cytomegalovirus (CMV) infection and related disease is a feared
complication after liver transplantation. Antiviral prophylaxis is recommended in clinical …

Background Limited data exist to describe sex‐based differences in the severity of
cytomegalovirus (CMV) infection after solid organ transplant (SOT). We sought to identify if a …

Background Cytomegalovirus (CMV) infection remains a major complication after heart
transplantation with varying prophylaxis strategies employed. We sought to determine the …

Immune fitness is critical in the pathogenesis and outcome of cytomegalovirus (CMV)
infection. CMV disease is seen almost exclusively among individuals with an immature or …

Cytomegalovirus (CMV) is the single most important pathogen affecting solid organ
transplant (SOT) recipients. CMV may occur as a primary infection in CMV-naïve patients …

Background The influence of cytomegalovirus (CMV) on recurrent hepatitis C virus (HCV) in
liver grafts is controversial. Our aim was to investigate the association between CMV …

A retrospective study was performed in liver transplant patients with high risk to develop
cytomegalovirus infection (CMV D+/R−) who were treated with valgancyclovir for 3 months …

Liver transplantation has become an important treatment modality for patients with end-
stage liver disease/cirrhosis, acute liver failure, and hepatocellular carcinoma. Although …